H1B Report
Side-by-side comparison

Microsoft Corporation vs Teva Pharmaceuticals USA, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Microsoft Corporation
WARank #5FEIN 91-1144442
Entity B
Teva Pharmaceuticals USA, Inc.
NJRank #FEIN 22-1734359

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricMicrosoft CorporationTeva Pharmaceuticals USA, Inc.
Total filings72,912341
Certified %94.30%80.06%
Denied %0.15%0.88%
Withdrawn %0.69%6.16%
Cert-withdrawn %4.85%12.90%
Rank#5
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateWANJ

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.3%, Cert-withdrawn 4.9%, Withdrawn 0.7%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%

Outcomes — Teva Pharmaceuticals USA, Inc.

DOL case-status mix.

Outcome breakdown: Certified 80.1%, Cert-withdrawn 12.9%, Withdrawn 6.2%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified80.1%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%
Certified80.1%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,407
FY20114,184
FY20124,005
FY20133,832
FY20143,674
FY20154,476
FY20164,919
FY20174,884
FY20185,457
FY20196,000
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20265,118
Teva Pharmaceuticals USA, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201110
FY201228
FY201311
FY201417
FY201534
FY201630
FY201751
FY201865
FY201940
FY20205
FY202113
FY20228
FY20232
FY20244
FY20257
FY20266

Top 5 occupations — Microsoft Corporation

Top 5 occupations — Teva Pharmaceuticals USA, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.